Canada

CVAA Occlusion Management Guideline for Central Venous Access Devices (2019)

83 controls. 0 other frameworks in our corpus share controls with it. Here is all of it, and how much of it you are already doing.

Page built . This page is derived from the framework corpus, which changes when the corpus is extended rather than daily.

83 controls 0 frameworks share controls with it Canada verified against its source document

Every control below is one this framework asks for. The right hand column counts how many other frameworks in our corpus carry the same control, which is the difference between doing this work once and doing it again for the next standard.

There is no implementation kit for this framework yet. The control list and the overlap above are free and complete.

What you already have

Frameworks whose controls overlap this one, most first. If you run any of them, the count is roughly what you have already evidenced.

No measured overlap with another framework in the corpus.

Every control

CodeControlAlso in
1.0-1Patency check of every lumen0
1.0-1bSterile saline flush with aspiration attempt0
1.0-2Classify the occlusion type0
1.0-3Investigate the blocked lumen promptly0
1.0-4No occluded lumen left untreated0
1.0-5Document patency and occlusion signs0
2.0-1Screen for mechanical occlusion0
2.0-2Assess for a positional device0
2.0-2aRepositioning measures for a positional CVAD0
2.0-2dScreen subclavian devices for pinch-off0
2.0-3Inspect and palpate for device damage0
2.0-4Act on reports suggesting tip malposition0
2.0-5Clear the mechanical obstruction0
2.0-5aHub flush once add-on devices are removed0
2.0-5bCheck dressing and catheter for kinks0
2.0-5cVerify the non-coring needle position0
2.0-5dReplace a clogged filter0
2.0-5eReplace tight sutures with sutureless securement0
2.0-5fNon-invasive correction of confirmed malposition0
2.0-5gPower flushing by a vascular access specialist0
2.0-5hRepair or replace a damaged device0
2.0-6Radiographic check of tip position0
2.0-6aPause infusion when malposition is suspected0
2.0-6bRemove the device when pinch-off is confirmed0
2.0-7Update the plan of care with prevention steps0
2.0-8Document findings, actions and response0
3.0-1Look for signs of thrombotic occlusion0
3.0-1aSaline approach when blood return is absent0
3.0-1bSmall-barrel syringe for aspiration only0
3.0-1cDye study for unresolved occlusion0
3.0-2Try to save the CVAD before replacement0
3.0-3Give alteplase promptly for suspected occlusion0
3.0-3aFollow organisational policy for thrombolysis0
3.0-3bHeparin does not restore patency0
3.0-3cConsent, order and infection risk before alteplase0
3.0-3dCompetency for thrombolytic administration0
3.0-3eTreat every occluded lumen0
3.0-3fRisk-benefit analysis for multi-lumen occlusion0
3.0-3gTreat older occlusions too0
3.0-3hStop infusions during dwell time0
3.0-4Alteplase dose and dwell time0
3.0-4aHow to instil alteplase0
3.0-4bDwell time of 30 minutes to 2 hours0
3.0-4cExtended dwell for fibrin sheath0
3.0-4dAspirate waste and flush after dwell0
3.0-5Alternatives for recurrent occlusion0
3.0-5aPush method over 30 minutes0
3.0-5bDual syringe technique for ports0
3.0-5cLow-dose infusion for fibrin sheath0
3.0-6aNotify MRP and consider imaging0
3.0-6bRemoval with an alternative access plan0
3.0-6cInvestigate for CVAD thrombosis0
3.0-7Monitor after thrombolytic for infection and thrombosis0
3.0-8Update care plan with prevention strategies0
3.0-9Document the occlusion episode0
4.0-1Assess for chemical occlusion0
4.0-2Clear chemical occlusion promptly0
4.0-2aFollow policy for chemical clearance0
4.0-2bCompetent staff only for chemical clearance0
4.0-2cDiscuss risks and obtain an order0
4.0-2dDirect instillation for partial occlusion0
4.0-2eNegative pressure for complete occlusion0
4.0-2fFill volume only0
4.0-3Notify MRP if clearance fails0
4.0-4Consider a thrombolytic after chemical failure0
4.0-5Revise care plan to prevent recurrence0
4.0-6Document chemical occlusion care0
5.0-1Educate and validate competency0
5.0-2Track outcomes of occlusion0
5.0-3Consider occlusion-prevention products0
5.0-M1Record device type and position0
5.0-M2Record patient demographics0
5.0-M3Record care setting0
5.0-M4Record therapies given through the device0
5.0-M5Record occlusion date and lumen0
5.0-M6Record the type of occlusion0
5.0-M7Record thrombolytic doses given0
5.0-M8Record the instillation method0
5.0-M9Record clearance outcomes and complications0
INTRO-01Why the guideline exists0
INTRO-02Aim and intended audience0
INTRO-03What the guideline covers and excludes0
INTRO-04How recommendations were developed0

Tell me when CVAA Occlusion Management Guideline for Central Venous Access Devices (2019) files something new

One email when a public company newly discloses something this framework governs, naming the company and what our corpus says it puts in scope. Nothing else, and one click to stop.

What this page is

A control-level reference for CVAA Occlusion Management Guideline for Central Venous Access Devices (2019), drawn from our framework corpus. Control codes and titles are references to the standard, not reproductions of it. The overlap counts and the auditor artefacts are our own work and are the part you will not find elsewhere.

Measure this against what you already run · All frameworks · Today's edition